PackTalk is a blog for the Healthcare Packaging Industry

Sterilization and the FDA Innovation Challenge


Published on November 7, 2019

By now, we are all familiar with the recent discussion around sterilization in the medical device industry. Ethylene oxide or EtO is the most popular sterilization modality in the industry accounting for approximately half of the market. EtO is a colorless gas, and long-term exposure can pose serious health risks. Some US communities located in and around EtO sterilization facilities have become increasingly concerned, ultimately forcing the FDA to take action. 

Good for community members, but potentially problematic for the medical device industry, including hospitals and patients who need the devices impacted by this. To put it bluntly, the FDA is in a bit of a Catch-22 situation with the question becoming: do they allow sterilizers to release harmful gas knowing it may be dangerous, or do they allow a shortage of medical devices that could save lives?

The FDA is currently working with sterilizers to reduce or abate the EtO being released into the atmosphere (99% destruction of EtO is required), while looking into new & innovative ways to sterilize medical devices. EtO has become the most popular form of sterilization for many reasons, with capacity and scalability being a top area of focus. A vaporized hydrogen peroxide sterilizer, for example, is roughly 80 to 100 cubic feet, whereas an EtO sterilizer is about 1500 to 3000 cubic feet.

The good news is that new medical devices can anticipate and prepare for a different sterilization modality. The bad news … that still leaves hundreds of thousands of medical devices on the market today using EtO. The FDA recently issued an innovation challenge to the industry. And while we will do everything we can to support our partners through this, we also look forward to the innovation that will result from this exercise. Any time we are forced to look at our industry through a different lens, resourcefulness and creativity emerge.


 

Jenn Goff
Director, Product Marketing | Oliver Healthcare Packaging

Comments (0)

Related Articles

New Nylon Opens Door for Companies Looking to Upgrade Packaging at a More Afford...

July 3, 2020

To our readers … you know by now that we never push our product through PackTalk. In this blog, we aim to educate & inspire, and ultimately start a discussion. But we’re breaking our own rule for this article.  The healthcare industry is conservative...

Learn More

Analysts Report Positive Signs for Elective Procedure Volume Recovery

July 3, 2020

During the peak of COVID-19, a majority of non-emergency or elective medical procedures were put on hold. The lack of procedures had a significant impact on the medical device industry and it’s still questionable when we’ll see procedure volume return to...

Learn More

Healthcare Agility in the Time of COVID-19

July 3, 2020

The healthcare world has faced a massive shift in recent months to focus on fighting the COVID-19 pandemic. The medical system has suffered unprecedented strain, and there has been global coordination in ways we have never before seen. Hospitals have...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.